Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 25(supl.2): 46-51, dez. 2003. ilus, graf
Article in Portuguese | LILACS | ID: lil-355613

ABSTRACT

A exposiçäo a fatores estressantes tem papel importante no desenvolvimento de transtornos depressivos. Os mecanismos envolvidos nesta relaçäo, no entanto, ainda säo pouco conhecidos, mas algumas evidências sugerem a participaçäo da formaçäo hipocampal: 1. o estresse pode causar alteraçöes plásticas no hipocampo, que incluem remodelaçäo dendrítica e inibiçäo de neurogênese. Drogas antidepressivas impendem estes efeitos, possivelmente por aumentarem a expressäo de fatores neurotróficos; 2. a facilitaçäo da neurotransmissäo serotoninérgica no hipocampo atenua conseqüências comportamentais do estresse e produz efeitos antidepressivos em modelos animais; 3. o antagonismo do principal neurotransmissor excitatório no hipocampo, o glutamato, produz efeitos semelhantes; 4. o hipocampo parece estar "hiperativo" em animais mais sensíveis em modelos de depressäo e em humanos resistentes à antidepressivos; 5. o hipocampo, em conjunto com o complexo amigdalar, parece ter papel fundamental na consolidaçäo e evocaçäo de memórias aversivas. Näo obstante estas evidências, o desafio futuro será o de tentar integrar os resultados destes diferentes campos (farmacológico, molecular, eletrofisiológico, clínico) em uma teoria unificadora sobre o papel do hipocampo na regulaçäo do humor e seus transtornos bem como nos efeitos de tratamentos antidepressivos


Subject(s)
Humans , Animals , Stress, Physiological , Depression/etiology , Depression/drug therapy , Hippocampus , Stress, Physiological , Serotonin Agents/therapeutic use , Excitatory Amino Acid Antagonists/therapeutic use , Hippocampus , Hippocampus/physiopathology , Hippocampus/metabolism , Disease Models, Animal , Serotonin/therapeutic use
2.
Braz J Psychiatry ; 25 Suppl 2: 46-51, 2003 Dec.
Article in Portuguese | MEDLINE | ID: mdl-14978587

ABSTRACT

Stress exposure is an important factor in the development of depressive disorders. Although the mechanisms of this relationship are largely unknown, several pieces of evidence point to an involvement of the hippocampal formation: 1. stressful stimuli cause remodeling of hipocampal pyramidal cells and inhibit neurogenesis in the dentate gyrus. Antidepressive drugs attenuate these effects, probably by increasing the expression of neurotrophic factors; 2. facilitation of serotonergic neurotransmission in the hippocampus attenuates behavioral consequences of stress and produce antidepressive-like effects in several animal models; 3. antagonism of glutamate, the main excitatory neurotransmitter of the hippocampus, also induce antidepressive-like effects; 4. increased hippocampal activity has been described in genetically selected rats that are more sensitive to depression models. Similar result was found in depressive patients that fail to respond to antidepressant drugs; 5. together with the amygdala, the hippocampus plays a key role on consolidation and evocation of aversive memories. The challenge for the future will be to integrate the results from these different fields (clinical, electrophysiological, pharmacological and molecular) in an unifying theory about the role of the hippocampus on mood regulation, depressive disorder and antidepressant effects.


Subject(s)
Depression/etiology , Hippocampus/physiology , Stress, Psychological/etiology , Animals , Depression/metabolism , Depression/physiopathology , Hippocampus/drug effects , Humans , Rats , Stress, Psychological/metabolism , Stress, Psychological/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...